UCB is a global biopharmaceutical company, with a focus on neurology and immunology. UCB’s ambition is to transform the lives of people living with severe diseases. We focus on neurology and immunology disorders – putting patients at the center of our world. We are Inspired by Patients. Driven by Science.

UCB is hosting the Brussels Future of Patient Data discussion.

Search Future Agenda insights by typing…

Close Search